Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease

Overview of attention for article published in Seminars in Hematology (ScienceDirect), February 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 7 X users
patent: 6 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 47 Mendeley

So far, Altmetric has seen 9 X posts from 7 X users, with an upper bound of 44,134 followers.

RT @bdermanmd: @azadi_soroush @CoachBon @NorthTxMSG @JackMAiello From another paper, which helps to describe the details a little better be…

@azadi_soroush @CoachBon @NorthTxMSG @JackMAiello From another paper, which helps to describe the details a little better between top down and bottom up mass spec https://t.co/OnF3m09OuR https://t.co/FWleH7hXoI

@NephRodby Mass spec of blood allows for rapid turnaround time and higher sensitivity for monoclonal proteins. What’s cool is this protein can be tracked over time (ie for Minimal residual disease). Think it will supplant spep for dx soon. Nice summary he…

RT @Myeloma_Doc: Review of mass spectrometry methods for detecting monoclonal immunoglobulins in multiple #myeloma minimal residual disease…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 5 additional X posts.